Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


15.11.2021

9 AIDS
1 Antimicrob Agents Chemother
1 BMC Cancer
1 BMC Neurol
14 Clin Infect Dis
2 HIV Med
15 J Acquir Immune Defic Syndr
2 J Infect Dis
2 J Virol
3 Lancet
1 MMWR Morb Mortal Wkly Rep
2 PLoS Med
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. CACHAY ER, Hasteh F, Mathews WC
    Using computer-assisted content analysis to advance anal dysplasia natural history research: a validation study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96273.
    PubMed         Abstract available

  2. ALTHOFF KN, Stewart CN, Humes E, Zhang J, et al
    The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96269.
    PubMed         Abstract available

  3. NEARY J, Langat A, Singa B, Kinuthia J, et al
    Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96270.
    PubMed         Abstract available

  4. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed         Abstract available

  5. BIRABAHARAN M, Strunk A, Kaelber DC, Smith DM, et al
    Sex differences in type 2 diabetes mellitus prevalence among persons with HIV: a cross-sectional analysis.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96272.
    PubMed         Abstract available

  6. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    PubMed         Abstract available

  7. DURSTENFELD MS, Sun K, Ma Y, Rodriguez F, et al
    Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96275.
    PubMed         Abstract available

  8. MUNOZ-MORENO JA, Carrillo-Molina S, Martinez-Zalacain I, Miranda C, et al
    Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96276.
    PubMed         Abstract available

  9. FOWLER MG, Aizire J, Sikorskii A, Atuhaire P, et al
    Growth deficits in antiretroviral and HIV exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months-of-age.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96277.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  10. ZHANG CX, Love MS, McNamara CW, Chi V, et al
    Pharmacokinetics and pharmacodynamics of clofazimine for treatment of cryptosporidiosis.
    Antimicrob Agents Chemother. 2021 Nov 8:AAC0156021. doi: 10.1128/AAC.01560.
    PubMed         Abstract available


    BMC Cancer

  11. ITALIANO A, Dinart D, Soubeyran I, Bellera C, et al
    Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
    BMC Cancer. 2021;21:1180.
    PubMed         Abstract available


    BMC Neurol

  12. PALLANGYO P, Mkojera ZS, Komba M, Mgopa LR, et al
    Burden and correlates of cognitive impairment among hypertensive patients in Tanzania: a cross-sectional study.
    BMC Neurol. 2021;21:433.
    PubMed         Abstract available


    Clin Infect Dis

  13. PUYAT JH, Shulha HP, Balshaw R, Campbell JR, et al
    How well does TSTin3D predict risk of active tuberculosis in the Canadian immigrant population? An External Validation Study.
    Clin Infect Dis. 2020 Jun 18. pii: 5859579. doi: 10.1093.
    PubMed         Abstract available

  14. JO Y, Shrestha S, Gomes I, Marks S, et al
    Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas.
    Clin Infect Dis. 2020 Jun 25. pii: 5862678. doi: 10.1093.
    PubMed         Abstract available

  15. WEINBERG A, Aaron L, Montepiedra G, Sterling TR, et al
    Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.
    Clin Infect Dis. 2020 Jul 28. pii: 5877271. doi: 10.1093/cid/ciaa1083.
    PubMed         Abstract available

  16. MARTINEZ L, Woldu H, Chen C, Hallowell BD, et al
    Transmission Dynamics in Tuberculosis Patients with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    Clin Infect Dis. 2020 Aug 8. pii: 5889983. doi: 10.1093/cid/ciaa1146.
    PubMed         Abstract available

  17. CAMPBELL JR, Al-Jahdali H, Bah B, Belo M, et al
    Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials.
    Clin Infect Dis. 2020 Aug 12. pii: 5891810. doi: 10.1093/cid/ciaa1169.
    PubMed         Abstract available

  18. MORTIMER TD, Pathela P, Crawley A, Rakeman JL, et al
    The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.
    Clin Infect Dis. 2021;73:e3146-e3155.
    PubMed         Abstract available

  19. MOOSA MS, Maartens G, Gunter H, Allie S, et al
    A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
    Clin Infect Dis. 2020 Aug 26. pii: 5897464. doi: 10.1093/cid/ciaa1255.
    PubMed         Abstract available

  20. ANSARI R, Rosen LB, Lisco A, Gilden D, et al
    Primary and Acquired Immunodeficiencies Associated With Severe Varicella-Zoster Virus Infections.
    Clin Infect Dis. 2021;73:e2705-e2712.
    PubMed         Abstract available

  21. MCCALLUM AD, Pertinez HE, Else LJ, Dilly-Penchala S, et al
    Intrapulmonary pharmacokinetics of first-line anti-TB drugs in Malawian tuberculosis patients.
    Clin Infect Dis. 2020 Aug 28. pii: 5898506. doi: 10.1093/cid/ciaa1265.
    PubMed         Abstract available

  22. KHALILI M, King WC, Kleiner DE, Jain MK, et al
    Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.
    Clin Infect Dis. 2020 Sep 1. pii: 5900012. doi: 10.1093/cid/ciaa1303.
    PubMed         Abstract available

  23. WORETA TA, Chalasani N
    Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for Concern.
    Clin Infect Dis. 2021;73:e3286-e3287.
    PubMed        

  24. KOJIMA N, Klausner JD
    Patients may accurately self-collect pharyngeal and rectal specimens for Neisseria gonorrhoeae and Chlamydia trachomatis infection: But is there benefit?
    Clin Infect Dis. 2020 Sep 2. pii: 5900658. doi: 10.1093/cid/ciaa1272.
    PubMed        

  25. ULFHAMMER G, Eden A, Antinori A, Brew BJ, et al
    Cerebrospinal Fluid viral load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study.
    Clin Infect Dis. 2021 Nov 8. pii: 6423171. doi: 10.1093.
    PubMed         Abstract available

  26. PILAROWSKI G, Marquez C, Rubio L, Peng J, et al
    Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.
    Clin Infect Dis. 2020 Dec 26. pii: 6052342. doi: 10.1093/cid/ciaa1890.
    PubMed         Abstract available


    HIV Med

  27. REYNOLDS Z, McCluskey SM, Moosa MYS, Gilbert RF, et al
    Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa.
    HIV Med. 2021 Nov 9. doi: 10.1111/hiv.13203.
    PubMed         Abstract available

  28. CUZIN L, Delobel P, Martin-Blondel G
    Letter to the editor.
    HIV Med. 2021 Nov 7. doi: 10.1111/hiv.13192.
    PubMed        


    J Acquir Immune Defic Syndr

  29. CICCULLO A, D'Angelillo A, Iannone V, Farinacci D, et al
    Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
    J Acquir Immune Defic Syndr. 2021;88:e5-e6.
    PubMed        

  30. CALZA L, Legnani G, Fulgaro C, Verucchi G, et al
    CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR DOLUTEGRAVIR/LAMIVUDINE/ABACAVIR.
    J Acquir Immune Defic Syndr. 2021 Nov 5. pii: 00126334-900000000-95763.
    PubMed        

  31. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Rebound HIV viremia with meningoencephalitis following antiretroviral therapy interruption after allogeneic bone marrow transplant.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95761.
    PubMed         Abstract available

  32. CHAI PR, Mohamed Y, Bustamante MJ, Goodman GR, et al
    DigiPrEP: A pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances.
    J Acquir Immune Defic Syndr. 2021 Nov 8. pii: 00126334-900000000-95762.
    PubMed         Abstract available

  33. EKSTRAND ML, Heylen E, Gandhi M, Steward WT, et al
    COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
    J Acquir Immune Defic Syndr. 2021;88:421-425.
    PubMed         Abstract available

  34. FRIEDMAN MR, Kempf MC, Benning L, Adimora AA, et al
    Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women.
    J Acquir Immune Defic Syndr. 2021;88:426-438.
    PubMed         Abstract available

  35. WAGNER Z, Mukasa B, Nakakande J, Stecher C, et al
    Impact of the COVID-19 Pandemic on Use of HIV Care, Antiretroviral Therapy Adherence, and Viral Suppression: An Observational Cohort Study From Uganda.
    J Acquir Immune Defic Syndr. 2021;88:448-456.
    PubMed         Abstract available

  36. SUPANAN R, Han WM, Harnpariphan W, Ueaphongsukkit T, et al
    Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    J Acquir Immune Defic Syndr. 2021;88:465-469.
    PubMed         Abstract available

  37. SEVELIUS JM, Glidden DV, Deutsch M, Welborn L, et al
    Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available

  38. RICE E, Wilder B, Onasch-Vera L, DiGuiseppi G, et al
    A Peer-Led, Artificial Intelligence-Augmented Social Network Intervention to Prevent HIV Among Youth Experiencing Homelessness.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available

  39. HOLLOWAY IW, Beltran R, Shah SV, Cordero L, et al
    Structural Syndemics and Antiretroviral Medication Adherence Among Black Sexual Minority Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available

  40. ARNOLD EA, Saberi P, Wong JO, Pollack LM, et al
    We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available

  41. LIGHTFOOT M, Milburn N, Loeb Stanga L
    Addressing Health Disparities in HIV: Introduction to the Special Issue.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available

  42. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;88:518-527.
    PubMed         Abstract available

  43. WILSON EC, Turner CM, Sanz-Rodriguez C, Arayasirikul S, et al
    Expanding the Pie-Differentiated PrEP Delivery Models to Improve PrEP Uptake in the San Francisco Bay Area.
    J Acquir Immune Defic Syndr. 2021;88.
    PubMed         Abstract available


    J Infect Dis

  44. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
    Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
    J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
    PubMed         Abstract available

  45. POPOVICH KJ
    Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
    J Infect Dis. 2021;223:543-546.
    PubMed        


    J Virol

  46. CHEN J, Zhao S, Cui Z, Li W, et al
    MicroRNA-376b-3p Promotes Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Restriction Factor TRIM22.
    J Virol. 2021 Nov 10:JVI0159721. doi: 10.1128/JVI.01597.
    PubMed         Abstract available

  47. VIEIRA VA, Adland E, Grayson NE, Csala A, et al
    Two distinct mechanisms leading to loss of virological control in the rare group of antiretroviral therapy-naive, transiently aviraemic children living with HIV.
    J Virol. 2021 Nov 10:JVI0153521. doi: 10.1128/JVI.01535.
    PubMed         Abstract available


    Lancet


  48. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    PubMed         Abstract available

  49. SAMARASEKERA U
    Etheldreda Nakimuli-Mpungu: innovator in mental health.
    Lancet. 2021;398:109.
    PubMed        

  50. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  51. AGATHIS NT, Annor FB, Coomer R, Hegle J, et al
    HIV Prevention Program Eligibility Among Adolescent Girls and Young Women - Namibia, 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1570-1574.
    PubMed         Abstract available


    PLoS Med

  52. BULSTRA CA, Hontelez JAC, Otto M, Stepanova A, et al
    Integrating HIV services and other health services: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003836.
    PubMed         Abstract available

  53. HONTELEZ JAC, Bulstra CA, Yakusik A, Lamontagne E, et al
    Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration.
    PLoS Med. 2021;18:e1003835.
    PubMed         Abstract available


    PLoS One

  54. SHAVA E, Bogart LM, Manyake K, Mdluli C, et al
    Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana.
    PLoS One. 2021;16:e0259508.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  55. PAQUIN-PROULX D, Lal KG, Phuang-Ngern Y, Creegan M, et al
    Preferential and persistent impact of acute HIV-1 infection on CD4(+) iNKT cells in colonic mucosa.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  56. MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
    COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: